Vessel fractional flow reserve (vFFR) vs. optical coherence tomography in chronic coronary syndromes (VISION-FFR).
Piotr Baruś, Adrian Bednarek, Karol Sadowski...
https://pubmed.ncbi.nlm.nih.gov/42573759/Actively Recruiting
Led by Medical University of Warsaw · Updated on 2025-02-25
200
Participants Needed
1
Research Sites
56 weeks
Total Duration
Researchers are studying the relationship between vessel fractional flow reserve vFFR and plaque characteristics in patients with chronic coronary syndrome who have intermediate grade coronary artery stenosis. This prospective, investigator-initiated study evaluates how well optical coherence tomography OCT measurements of plaque morphology and minimal lumen area correlate with vFFR, a functional index derived from angiography. The study also explores how factors like age, sex, diabetes, and kidney function affect these relationships. Participants undergo coronary angiograms and OCT to assess the coronary arteries with intermediate stenosis ranging from 40% to 80%. The study is a single-center, non-randomized, single-arm observational design where all patients receive diagnostic evaluations including OCT and vessel fractional flow reserve measurements. These methods focus on assessing plaque types such as fibrotic, calcific, lipidic, and thin cap fibroatheroma. During the study, participants provide written informed consent and are monitored for correlations between vFFR and minimal lumen area at the time of their procedure. Follow-up includes tracking major adverse cardiovascular events over 36 months. The study collects detailed imaging, clinical data, and patient history to better understand coronary artery disease in this population, with ongoing safety and health assessments throughout the study period.
CONDITIONS
Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve
M
Mariusz Tomaniak, MD, PhD, Assoc. Prof.
P
Piotr Baruś, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Medical University of Warsaw
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo optical coherence tomography and vessel fractional flow reserve evaluation of coronary arteries with intermediate to severe stenosis.
1 visit (in-person)
Duration - Up to 36 months
Participants are monitored for major adverse cardiovascular events following the diagnostic evaluation.
Follow-up visits as per routine clinical care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Piotr Baruś, Adrian Bednarek, Karol Sadowski...
https://pubmed.ncbi.nlm.nih.gov/42573759/Medical University of Warsaw
Lead Sponsor